Connection
Peter Anderson to Cost-Benefit Analysis
This is a "connection" page, showing publications Peter Anderson has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.180 |
|
|
|
-
Kile DA, MaWhinney S, Aquilante CL, Rower JE, Castillo-Mancilla JR, Anderson PL. A population pharmacokinetic-pharmacogenetic analysis of atazanavir. AIDS Res Hum Retroviruses. 2012 Oct; 28(10):1227-34.
Score: 0.072
-
Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009 Jun 27; 373(9682):2234-46.
Score: 0.059
-
Puccinelli M, Mayer KH, Esquivel-Mendoza JA, Porras A, Psaros C, Krakower D, Doblecki-Lewis S, Anderson PL, Mimiaga MJ, Safren SA. Life-steps for PrEP nurse-delivered adherence intervention: Protocol for a multisite randomized clinical trial. Contemp Clin Trials. 2026 Sep; 168:108405.
Score: 0.048